Atyurmila Chakraborty | Pharmacology | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Atyurmila Chakraborty
Affiliation SRM Institute of Science and Technology, Kattankulathur
Country India
Scopus ID 57808966100
Documents 15
Citation 46 citations (40 citing documents)
h-index 4
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0002-1770-5491

Atyurmila Chakraborty

SRM Institute of Science and Technology, Kattankulathur, India

The Best Researcher Award recognizes sustained scholarly activity, research productivity, and contributions to scientific knowledge through peer-reviewed publications, academic engagement, and measurable research impact. Atyurmila Chakraborty is affiliated with SRM Institute of Science and Technology, Kattankulathur, India, with research indexed in Scopus under Author ID 57808966100. Available bibliometric indicators demonstrate active scholarly contributions within the field of pharmacology and related biomedical sciences.[1]

Abstract

This article presents an academic overview of Atyurmila Chakraborty’s research profile in relation to the Best Researcher Award. The assessment considers scholarly productivity, publication record, citation performance, subject specialization, and professional visibility through internationally recognized indexing services. The available bibliometric information indicates active participation in pharmacology research and continued contribution to peer-reviewed scientific literature.[1]

Keywords

Best Researcher Award; Pharmacology; Scopus Author; Scientific Publications; Citation Analysis; Research Impact; Biomedical Research; Academic Excellence; International Popular Scientist Awards.

Introduction

Academic recognition programs acknowledge researchers who consistently contribute to scientific advancement through rigorous investigation, publication, collaboration, and dissemination of knowledge. Bibliometric indicators such as indexed publications, citations, and the h-index provide standardized measures that complement expert peer evaluation during award assessment processes.[2]

Research Profile

Atyurmila Chakraborty’s research profile demonstrates engagement with pharmacological sciences through scholarly publications indexed in Scopus. The available metrics include fifteen indexed documents, forty-six citations, and an h-index of four. These indicators reflect an active research portfolio and measurable scholarly visibility within the academic community.[1]

  • Primary research discipline: Pharmacology.
  • Institution: SRM Institute of Science and Technology.
  • Internationally indexed author profile.
  • Research performance documented through bibliometric indicators.

Research Contributions

Research contributions within pharmacology commonly encompass experimental studies, therapeutic investigations, drug discovery, toxicological evaluation, pharmacokinetic analysis, and translational biomedical research. Scholarly publications contribute to scientific communication by presenting validated methodologies, reproducible findings, and evidence-based interpretations for the wider research community.[2]

Publications

The available Scopus profile records fifteen indexed scholarly documents. Publications indexed by international databases contribute to citation visibility, research accessibility, and scholarly evaluation. Where applicable, published articles include Digital Object Identifiers (DOIs), enabling persistent identification and reliable academic referencing.[1][3]

Research Impact

Research impact is commonly evaluated through publication quality, citation frequency, scholarly collaboration, and sustained contribution to disciplinary knowledge. Citation metrics, together with peer-reviewed publications and recognized author profiles, provide objective evidence supporting research visibility and scientific influence.[2]

Award Suitability

Based on the publicly available academic indicators, Atyurmila Chakraborty demonstrates characteristics commonly considered during evaluations for the Best Researcher Award, including indexed publications, measurable citation performance, an established Scopus author profile, and active research engagement in pharmacology. Final award decisions remain dependent upon comprehensive review criteria established by the organizing committee of the International Popular Scientist Awards.[4]

Conclusion

Atyurmila Chakraborty’s documented scholarly profile illustrates ongoing participation in pharmacology research supported by internationally indexed publications and recognized bibliometric indicators. Such academic achievements represent important components of professional research evaluation and provide a foundation for consideration within competitive scientific recognition programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Atyurmila Chakraborty, Author ID 57808966100. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57808966100
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences.
  3. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) Handbook.https://doi.org/
  4. International Popular Scientist Awards. (n.d.). Award information and nomination guidelines.https://popularscientist.com/

Sasmita Kumari Acharjya | Pharmacology | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Sasmita Kumari Acharjya
Affiliation Roland Institute Of Pharmaceutical Sciences
Country India
Scopus ID 37048714200
Documents 17
Citations 139 (Citations by 126 documents)
h-index 8
Subject Area Pharmacology
Event International Popular Scientist Awards
ORCID 0000-0002-4372-1348

Sasmita Kumari Acharjya
Roland Institute Of Pharmaceutical Sciences

Sasmita Kumari Acharjya, affiliated with Roland Institute Of Pharmaceutical Sciences, has established a documented research profile within the field of pharmacology through peer-reviewed scholarly publications indexed in Scopus. The academic record demonstrates sustained contributions to pharmaceutical sciences, scientific communication, and citation impact that support consideration for the Best Researcher Award. Quantitative indicators including indexed publications, citations, and h-index provide measurable evidence of scholarly productivity and influence within the research community.[1]

Abstract

This academic recognition profile summarizes the documented scholarly achievements of Sasmita Kumari Acharjya based on publicly available bibliographic information, institutional affiliation, and indexed research metrics. The profile highlights publication activity, citation performance, research specialization in pharmacology, and broader scientific contributions relevant to evaluation for the Best Researcher Award. Academic indicators presented here are intended to provide an objective overview of research productivity and scientific influence.[1]

Keywords

  • Best Researcher Award
  • Pharmacology
  • Pharmaceutical Sciences
  • Scopus Author Profile
  • Research Excellence
  • Scientific Publications

Introduction

Recognition through research awards is generally based on measurable scholarly accomplishments, originality of scientific investigations, publication quality, citation influence, and contribution to knowledge advancement. Researchers working within pharmaceutical sciences contribute to improved understanding of therapeutic agents, drug discovery, pharmacological mechanisms, and healthcare innovation. Bibliometric indicators together with peer-reviewed publications provide an objective basis for evaluating academic performance.[2]

Research Profile

According to indexed author information, Sasmita Kumari Acharjya has authored or co-authored 17 Scopus-indexed publications with an h-index of 8 and 139 citations generated by 126 citing documents. These metrics indicate continued scholarly engagement and measurable research visibility within pharmacology and related pharmaceutical disciplines.[1]

  • Primary specialization: Pharmacology.
  • Institutional affiliation: Roland Institute Of Pharmaceutical Sciences.
  • Internationally indexed scholarly publications.
  • Established citation record supporting research visibility.

Research Contributions

The available publication record reflects participation in pharmaceutical and pharmacological research through peer-reviewed scientific literature. Contributions support continued advancement of pharmaceutical knowledge by disseminating research findings within recognized scholarly journals. Such publications contribute to cumulative scientific evidence and facilitate future investigations by the wider research community.[1]

Publications

The researcher’s publication portfolio includes peer-reviewed articles indexed by Scopus covering topics within pharmacology and pharmaceutical sciences. Publications possessing Digital Object Identifiers (DOIs) provide permanent scholarly references and facilitate international accessibility through digital publishing platforms.[3]

  • Scopus-indexed journal publications.
  • Peer-reviewed scientific articles.
  • DOI-enabled scholarly publications.
  • Research outputs contributing to pharmaceutical science literature.

Research Impact

Citation metrics provide evidence that published research has been referenced by subsequent scientific work. An h-index of 8 together with 139 citations demonstrates measurable academic influence and continued utilization of the published literature by researchers working in related scientific domains.[1]

Award Suitability

Based on documented publication activity, citation performance, institutional affiliation, and recognized research specialization, Sasmita Kumari Acharjya demonstrates characteristics commonly considered during evaluations for academic research recognition. Assessment for the Best Researcher Award may appropriately consider scholarly productivity, citation influence, publication quality, ethical research practices, and overall contribution to pharmacological sciences alongside established award criteria.[1]

Conclusion

The available academic profile indicates a sustained record of scientific publication and measurable research influence within pharmacology. Indexed publications, documented citations, and continued scholarly engagement collectively provide objective evidence supporting academic recognition and consideration within international research award programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Sasmita Kumari Acharjya, Author ID 37048714200. Scopus.https://www.scopus.com/authid/detail.uri?authorId=37048714200
  2. ORCID. (n.d.). ORCID record for Sasmita Kumari Acharjya.https://orcid.org/0000-0002-4372-1348
  3. International DOI Foundation. (n.d.). Digital Object Identifier (DOI) Handbook.

Abdel Abdel-Rahman | Cardiovascular Pharmacology | Innovative Research Award

Published on by International Popular Scientist Awards

Innovative Research Award

Abdel Abdel-Rahman
East Carolina University, United States
Abdel Abdel-Rahman
Affiliation East Carolina University
Country United States
Scopus ID 7102847207
Documents 181
Citations 3711
h-index 33
Subject Area Cardiovascular Pharmacology
Event International Popular Scientist Awards
ORCID
0000-0002-3461-2190

Abdel Abdel-Rahman  the Innovative Research Award recognizes distinguished scientific contributions in the field of cardiovascular pharmacology and related biomedical sciences. Abdel Abdel-Rahman of East Carolina University has developed an extensive scholarly portfolio that reflects sustained academic productivity, interdisciplinary collaboration, and measurable scientific impact in cardiovascular research and pharmacological sciences.[1] His publication record, citation performance, and recognized expertise in cardiovascular pharmacology position him as a notable contributor within the international scientific community.[2]

Abstract

Abdel Abdel-Rahman has contributed extensively to cardiovascular pharmacology through scholarly investigations addressing vascular physiology, autonomic regulation, pharmacodynamics, and therapeutic mechanisms associated with cardiovascular disorders. His academic output demonstrates a strong emphasis on translational biomedical research and pharmacological innovation.[1] With 181 indexed documents, 3711 citations, and an h-index of 33, his work has achieved significant scholarly visibility and international academic engagement.[2] The Innovative Research Award acknowledges these contributions within the framework of the International Popular Scientist Awards program.

Keywords

The Innovative Research Award in Cardiovascular Pharmacology recognizes pioneering contributions that advance the understanding and treatment of cardiovascular diseases through pharmacological innovation and biomedical discovery. This award celebrates researchers whose work bridges Pharmacological Research, Biomedical Sciences, and Translational Medicine to develop safer, more effective cardiovascular therapeutics. It honors excellence in innovative drug development, clinical applications, and transformative scientific research that improves global cardiovascular health outcomes.

Introduction

Cardiovascular pharmacology remains an essential scientific discipline within biomedical research due to its role in understanding cardiovascular diseases, therapeutic mechanisms, and pharmacological interventions. Research within this domain contributes to the development of treatment strategies for hypertension, vascular dysfunction, and cardiac pathophysiology.[2]

Abdel Abdel-Rahman has maintained a sustained academic presence in this field through research activities associated with East Carolina University. His work demonstrates consistent scholarly productivity and scientific engagement within cardiovascular and pharmacological sciences.[1] The International Popular Scientist Awards recognize researchers whose scientific achievements contribute meaningfully to academic advancement and interdisciplinary biomedical knowledge.

Research Profile

The research profile of Abdel Abdel-Rahman reflects extensive engagement in cardiovascular pharmacology, autonomic regulation, neuropharmacology, and vascular function research. His scientific investigations have addressed mechanisms influencing blood pressure regulation, pharmacological responses, and cardiovascular signaling pathways.[2]

Bibliometric indicators associated with his scholarly output demonstrate sustained academic visibility. According to indexed scholarly databases, his work has accumulated thousands of citations and a notable h-index, indicating both productivity and citation influence within the biomedical research community.[2]

Research Contributions

Abdel Abdel-Rahman’s scientific contributions include investigations into cardiovascular regulation, pharmacological interactions, and neurovascular signaling. His studies have explored physiological mechanisms underlying vascular control and the pharmacodynamics associated with cardiovascular therapeutics.[5]

Several publications associated with his research profile have examined experimental pharmacological models relevant to cardiovascular disease mechanisms and therapeutic responses. These contributions have enhanced understanding of autonomic modulation and vascular pharmacology within preclinical and translational research contexts.[1]

Publications

The publication portfolio of Abdel Abdel-Rahman includes peer-reviewed articles focusing on cardiovascular pharmacology and related biomedical sciences. His indexed research output demonstrates continuity in scientific productivity and interdisciplinary collaboration.[1]

Representative publications indexed within international scholarly databases have contributed to citation growth and broader academic dissemination.[2]

Research Impact

The scientific impact of Abdel Abdel-Rahman’s work is reflected through citation metrics, publication visibility, and continued relevance within cardiovascular pharmacology research. His research output has contributed to ongoing academic discussions concerning cardiovascular physiology, vascular pharmacology, and therapeutic intervention strategies.

An h-index of 33 indicates consistent citation performance across multiple scholarly works, while a citation count exceeding 3700 demonstrates sustained engagement by the international biomedical research community.[2] These indicators collectively support the scholarly significance of his research activities.

Award Suitability

The Innovative Research Award recognizes individuals demonstrating substantial scientific contributions, scholarly influence, and research advancement within their respective disciplines. Abdel Abdel-Rahman’s academic profile aligns with these criteria through sustained publication activity, recognized citation impact, and research contributions within cardiovascular pharmacology.[1]

His scientific work reflects methodological rigor, interdisciplinary relevance, and ongoing contributions to pharmacological sciences. Participation in the International Popular Scientist Awards further highlights the importance of promoting impactful biomedical research and academic excellence.[1]

Conclusion

Abdel Abdel-Rahman’s scholarly record demonstrates a sustained commitment to cardiovascular pharmacology and biomedical research. Through extensive publication activity, measurable citation influence, and interdisciplinary scientific contributions, he has established a recognized academic presence within the international research community.[2] The Innovative Research Award acknowledges these accomplishments within the broader context of scientific advancement and research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Abdel Abdel-Rahman, Author ID 7102847207. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102847207
  2. ORCID. (n.d.). ORCID profile for Abdel Abdel-Rahman.
    https://orcid.org/0000-0002-3461-2190
  3. International Popular Scientist Awards. (n.d.). Research recognition and scientific excellence initiatives.
    https://popularscientist.com/
  4. Katzung, B. G. (2021). Basic and Clinical Pharmacology. McGraw-Hill Education